This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

DUPHAT 2025 served as a vibrant platform uniting global and local companies, fostering innovation, creating new business opportunities, and propelling the growth of the UAE's pharmaceutical sector in ...

View the full release here: "I'm excited to welcome Alastair to Chemify to help us with building and scaling our ability to ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...

In a footnote of his opinion, Judge Joshua Roberts wrote, “A more cynical view of the circumstances is that plaintiffs’ ...

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

Moderna (MRNA) was on track to see a weekly gain of 21% as of Wednesday. Shares of the vaccine maker rose 11.7% the prior day following the first reported bird flu death in the US. The stock was up as ...

ShareThe recent wave of delistings from the Nigerian Exchange (NGX) by notable companies such as Flour Mills of Nigeria (FMN) and GlaxoSmithKline (GSK) has sparked conversations among investors, ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...